Receptos Establishes R&D Collaboration with Ono Pharmaceutical

Receptos will use its proprietary technology platform to produce high resolution protein crystal structures of the discovery target and drive Ono's structure-based drug design efforts.

San Diego-based drug developer Receptos has established an R&D collaboration with Japan's Ono Pharmaceutical for small molecule modulators of an undisclosed G-protein coupled receptor (GPCR) target.

Receptos will use its proprietary technology platform to produce high resolution protein crystal structures of the discovery target and drive Ono's structure-based drug design efforts.

Ono will pay an undisclosed upfront payment, as well as research funding and milestone payments.

Kazuhito Kawabata, Ph.D., executive officer and executive director, Discovery and Research at Ono, noted, "Receptos' GPCR protein crystal structure determination platform technolo